RESPONSE ONCOLOGY INC
10-Q, EX-27, 2000-08-14
SPECIALTY OUTPATIENT FACILITIES, NEC
Previous: RESPONSE ONCOLOGY INC, 10-Q, EX-10.U, 2000-08-14
Next: SPRINGHILL LAKE INVESTORS LTD PARTNERSHIP, NT 10-Q, 2000-08-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF RESPONSE ONCOLOGY, INC. FOR THE SIX MONTHS ENDED JUNE
30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<EXCHANGE-RATE>                                      1
<CASH>                                           6,777
<SECURITIES>                                         0
<RECEIVABLES>                                   18,761
<ALLOWANCES>                                     2,597
<INVENTORY>                                      3,519
<CURRENT-ASSETS>                                47,575
<PP&E>                                          17,020
<DEPRECIATION>                                  13,093
<TOTAL-ASSETS>                                 116,193
<CURRENT-LIABILITIES>                           56,238
<BONDS>                                              0
                                0
                                         17
<COMMON>                                           123
<OTHER-SE>                                      47,253
<TOTAL-LIABILITY-AND-EQUITY>                   116,193
<SALES>                                         70,225
<TOTAL-REVENUES>                                70,225
<CGS>                                           48,067
<TOTAL-COSTS>                                   70,500
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                   286
<INTEREST-EXPENSE>                               1,657
<INCOME-PRETAX>                                   (665)
<INCOME-TAX>                                      (249)
<INCOME-CONTINUING>                               (416)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                      (416)
<EPS-BASIC>                                       (.03)
<EPS-DILUTED>                                     (.03)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission